Eli Lilly and Company (LLY.BA)
Develops and sells insulin, cancer drugs, and medications for diabetes and immune diseases
34,880.00+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+87.0%
The outlook
Eli Lilly trades near its 52-week highs and well above its moving averages, reflecting strong recent momentum. The stock carries a trailing P/E of 0.2, which appears unusually low and warrants verification. Analyst coverage data isn't available in your snapshot, so checking detailed consensus ratings separately would help round out the picture.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range99% of the way from its 52-week low to high
Market cap
$7.78T
52-wk high
35,160.00
52-wk low
14,850.00
50-day avg
31,302.80
200-day avg
27,697.70
Trailing P/E
0.2